Mazdutide (5 mg Vial)
This reference covers Mazdutide (5 mg Vial) in vial format: reconstitution steps, the concentration each volume produces, syringe-unit conversions and storage conditions for the lyophilized and reconstituted material.
Synonyms/Alias: Mazdutide
Purity: Specification by inquiry
Custom Peptide Support
- Sequence, purity and scale confirmation
- CoA and technical documentation requests
- API, research and cosmetic peptide options
- Distributor and institution quotation support
This reference covers Mazdutide (5 mg Vial) in vial format: reconstitution steps, the concentration each volume produces, syringe-unit conversions and storage conditions for the lyophilized and reconstituted material.
Quickstart
Reconstitute: Add 3.0 mL bacteriostatic water → ~ 1.67 mg/mL concentration (standard protocol).
Typical weekly range: 2.5–6 mg once weekly with gradual titration.
Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. [7]
Notes
Practical considerations for safe and effective administration. Use a new sterile insulin syringe for each weekly injection; dispose in a proper sharps container. [9] Rotate injection sites weekly (abdomen, thighs, upper arms) to minimize local irritation and lipoatrophy. [8] [10] For doses requiring >3 mL volume, split into two separate injections at different sites for comfort and absorption. Allow reconstituted vials to reach room temperature before withdrawing dose to reduce viscosity. Document dose, injection site, and any side effects to track response and optimize protocol.
Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.
Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.
Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.
Peptide Vials (Mazdutide, 5 mg each): 8 weeks ≈ 6 vials (Weeks 1–4: 2 vials; Weeks 5–8: 4 vials)
12 weeks ≈ 10 vials (Weeks 1–4: 2 vials; Weeks 5–12: 8 vials)
16 weeks ≈ 14 vials (Weeks 1–4: 2 vials; Weeks 5–16: 12 vials)
Insulin Syringes (U‑100, 1 mL or 3 mL capacity): Per week: 1 syringe (once‑weekly dosing)
8 weeks: 8 syringes
12 weeks: 12 syringes
16 weeks: 16 syringes
Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for standard reconstitution. 8 weeks (6 vials): 18 mL → 2 × 10 mL bottles
12 weeks (10 vials): 30 mL → 3 × 10 mL bottles
16 weeks (14 vials): 42 mL → 5 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each week. Per week: 2 swabs
8 weeks: 16 swabs → recommend 1 × 100‑count box
12 weeks: 24 swabs → recommend 1 × 100‑count box
16 weeks: 32 swabs → recommend 1 × 100‑count box
Product Gallery
Quick Inquiry
Customer Support & Price Inquiry
Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.
Email: kongq687@gmail.com
Address: Huangpu District, Guangzhou, China